Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

Titan Company - Q2FY21 First Cut - ICICI Securities

Posted On: 2020-10-28 09:22:16


(CMP: Rs. 1217; MCap: Rs. 108123 crore)

Titan reported Q2FY21 results, wherein revenues were in-line with estimates (as guided by the management), however profitability was below our estimates owing to gross margin deterioration due to unfavourable product mix. Overall revenues (including bullion sales of Rs. 391 crore) declined by 2% YoY to Rs. 4553.0 crore. EBITDA margins declined by 430 bps YoY to 6.9% (I-direct estimate: 9.0%). EBITDA came in at Rs. 313 crore. Provision of Rs. 34 crore towards overdue margin money from a broker also impacted the profitability. PAT for the quarter declined by 45% YoY to Rs. 173.0 crore (I-direct estimate: Rs. 219 crore). The management indicated on ground the demand scenario has been improving and company has witnessed high single digit growth (like for like) during the first ten days of festive season. Company continues to gain market share as unorganised regional players are currently hovering at 55-70% recovery rate.

The Group has recognized a loss of Rs. 485 crores during the quarter in other expense due to ineffective hedges. Had the hedge been "effective", revenue and Other expenses would have been lower by the same amount without any impact on EBIT. The company expects ineffective hedges to reduce substantially as predictability of sales improves.

Q2FY21 Earning Summary

- As guided by the management in its pre-quarterly update, the jewellery division witnessed strong revival with recovery rate of 98% in Q2FY21 (on a low base of Q2FY20). Revenue for the jewellery division grew by 7.2% YoY to Rs. 3983 crore (including bullion sale of Rs. 391 crore). Excluding the bullion sale, revenue for the division declined by 2% YoY. The growth was mainly driven by demand for gold coins and plain gold jewellery owing to surge in gold prices. Demand for studded jewellery has increased on QoQ basis to 26% (compared to 18% in previous quarter), however still remains below on YoY basis (Q2FY20: 38%). Watches division recovery is sluggish with sales reaching 55% of pre-Covid levels in Q2FY21 (September: 70%). Revenue for the division de-grew by 44% YoY to Rs. 401 crore. Overall revenues declined by 2% YoY to Rs. 4553.0 crore

- Gross margins were impacted substantially owing to lower share of studded ratio and increase in sales of gold coins (14% vs. 3% YoY). Adjusted gross margins declined by ~670 bps YoY. Company has embarked upon cost saving initiatives with employee and other expenses (excluding ineffective hedges) declining by 19% and 25%, respectively. Advertisement spends came down sharply by 57% YoY to Rs. 61.0 crore. Company reported EBITDA of Rs. 313 crore (down 40% YoY). PAT came in at Rs. 173.0 crore (down 45% YoY).

Overall sales recovery of 89% in Q2FY21 has been encouraging given the challenging scenario. With the upcoming festive season, management expects momentum to sustain with full normalcy expected by Q4FY21. Company expects pick-up in pace in the share of studded jewellery in Q3FY21 which would aid gross margins going forward. Working capital management has been the priority of the company. As on 30th September company is net cash surplus vs net debt as on 30th March 2020.

We will soon be coming out with a detailed report.

Shares of Titan Company Limited was last trading in BSE at Rs.1217.9 as compared to the previous close of Rs. 1232.65. The total number of shares traded during the day was 309952 in over 9932 trades.

The stock hit an intraday high of Rs. 1242 and intraday low of 1186. The net turnover during the day was Rs. 378217786.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Auto Sector - Monthly Volume Round-up - Nov 20 - Reliance Securities

What do brokerages say on Burger King India Limited's IPO?

The Phoenix Mills - Potential fund infusion may usher in growth - ICICI Securities

Godrej Agrovet - Beneficiary of 60% increase in palm oil prices - ICICI Securities

Automobiles (wholesale) - Wholesale dispatches rise amidst modest retail trends - ICICI Securities

Oil & Gas - Sector Update - Dec 2020 - ICICI Direct

Phoenix Mills (Buy): Asset monetisation at favourable terms... - ICICI Direct

Aditya Makharia's views on November Auto Sales Number for November 2020 - HDFC Securities

Burger King India - IPO Review - ICICI Direct

Quant Pick - LIC Housing Finance - ICICI Direct

Tech Mahindra - Analyst Meet Update - ICICI Direct

Gladiator Stocks - Crompton Greaves Consumer Electricals - ICICI Direct

Derivatives Monthly Outlook - Nifty support at 12800 for ongoing momentum...

Quant Pick - Sun Pharmaceuticals - ICICI Direct

Monetary Policy - Expectation from YES Securities

Sector Update on Asset Management Companies - Subdued but improvement expected - HDFC Securities

Pre Monetary Policy View - Dec, 2020 - Lakshmi Iyer, President and CIO (Debt) & Head Products, Kotak Mutual Fund

Maintain REDUCE on Siemens - Smart recovery priced in - HDFC Securities

Banking Sector Credit Trends - Growth continues to moderate - HDFC Securities

Q2 FY21 GDP: Light at the end of the tunnel - YES Securities

Siemens - Q4 FY20 Result Update - YES Securities

Super action in Home Loans - SBIN, ICICIBC, AXSB, HDFC and LICHF gaining share - YES Securities

Polymer price tracker - Dec 1, 2020 - PVC prices continue to tread higher - ICICI Securities

Bajaj Finance - Company Update - Dec 2020 - ICICI Direct

Siemens Ltd - Healthy revival in orders and margins - ICICI Securities

Covid Recovery Pulse - Nov 30, 2020 - Festive positivity continues in auto retails, e-way bill generation improves...

Derivatives Weekly View (November 27): Momentum expected to continue in broader markets with Nifty support at 12800...

Derivatives Strategy - Positional Option - ICICI Direct

Preview on RBI Monetary Policy - December 2020 - Shanti Ekambaram, Group President - Consumer Banking, Kotak Mahindra Bank

10 things you should know about Burger King India Limited

Views of HDFC Securities and Acuité Ratings & Research on Q2FY21 GDP Numbers

Rollover Report for November 2020 - December 2020: Angel Broking

Initiating Coverage on Godrej Properties - The housing factory - HDFC Securities

Burger King IPO - Angel Broking

Rollover Analysis - Record foreign inflows pushes Nifty to 13k - YES Securities

Ceramic tiles industry - Market share gains sustain for top branded players - ICICI Securities

Gas sector - CGD: Competition to hit margins, volumes and lead to derating - ICICI Securities

Cement - Prices resilient in Q3; consensus upgrades to continue - ICICI Securities

Specialty chemicals - Price trend in Sep-20 - ICICI Securities

Timken India - Q2FY21 Company Update - ICICI Direct

Upgrade in target price of IDFC First Bank - Angel Broking

Laurus Labs stake acquisition in Richore Lifesciences - Angel Broking

Shares of Lakshmi Vilas Bank (LVB) suspended from trading - Angel Broking

Initiating Coverage on Sundram Fasteners - Fastening growth - HDFC Securities

Astral Poly Technik - Scalability to further improve with storage tanks foray - ICICI Securities

Vardhman Special Steel - Q2FY21 Company Update - ICICI Direct

Initiating Coverage - Advanced Enzyme Technologies - ICICI Direct

L&T - Secures Large Contract - Nov 25, 2020 - Angel Broking

Alembic Pharmaceuticals - Tentative Approval for JV - Angel Broking

Drug launch by Lupin - Tacrolimus Capsules - Angel Broking



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019